ArticleFrontiers in medicine2026
Endobronchial valves placement for persistent air leaks in critically ill patients: chest tube removal and competing risk of death.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Persistent air leaks due to alveolar-pleural or peripheral bronchiolar-pleural fistulas remain challenging in critically ill patients requiring respiratory support. We assessed the effectiveness and safety of endobronchial valve placement in this setting, accounting for the competing risk of death. Methods: We conducted a single-center, retrospective cohort study of consecutive critically ill adults requiring invasive mechanical ventilation or high-flow nasal oxygen for acute respiratory failure who underwent endobronchial valve placement for alveolar-pleural or peripheral bronchiolar-pleural fistulas. The primary outcome was time to chest tube removal, analyzed using a competing risk analysis in which in-hospital death was treated as the competing event. Secondary outcomes included in-hospital mortality, procedural safety, and exploratory analyses of the response to early post-procedural air leaks. Results: A total of 38 patients were included. The cumulative incidence of chest tube removal reached 60.5, 71.1, and 94.7% by days 10, 14, and 20, respectively, after endobronchial valve placement; the corresponding cumulative incidence of in-hospital death was 2.6% by day 14. The median time to chest tube removal was 7.5 days. In Fine-Gray models, adjusted for clinically relevant covariates, older age was found to be associated with a lower incidence of chest tube removal (subdistribution hazard ratio [sHR], 0.96 per year; 95% CI, 0.93-0.98; Conclusion: In critically ill patients with persistent air leaks, endobronchial valve placement was associated with rapid chest tube removal and a low early competing risk of death. These findings support further prospective evaluation of this approach in high-risk patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.